Flax Pond Capital’s Organogenesis Holdings ORGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.03M Buy
422,591
+2,500
+0.6% +$6.11K 0.72% 41
2026
Q1
$996K Sell
420,091
-4,100
-1% -$14.2K 0.8% 34
2025
Q4
$2.2M Buy
+424,191
New +$2.06M 1.63% 30

Other funds holding ORGO

Flax Pond Capital's ORGO Position: Q2 2026 in Review

Flax Pond Capital increased its Organogenesis Holdings (ORGO) stake by 0.6% in Q2 2026, buying an estimated $6.11K and bringing the position to 422,591 shares worth $1.03M. The position accounts for 0.72% of the portfolio, ranked #41.

Flax Pond Capital first reported a position in ORGO in Q4 2025 and has held it in 3 quarters since. The position peaked at $2.2M in Q4 2025. 134 funds tracked by Wall St. Rank hold ORGO as of Q2 2026.

  • Flax Pond Capital held 422,591 shares of Organogenesis Holdings worth $1.03M as of Q2 2026.
  • Flax Pond Capital bought 2,500 Organogenesis Holdings shares in Q2 2026, an estimated $6.11K.
  • Organogenesis Holdings made up 0.72% of Flax Pond Capital's portfolio in Q2 2026, its #41 holding.
  • Flax Pond Capital first reported a position in Organogenesis Holdings in Q4 2025 and has held it in 3 quarters since.
  • Flax Pond Capital's Organogenesis Holdings position peaked at $2.2M in Q4 2025.
  • 134 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q2 2026.

Based on Flax Pond Capital's 13F filing for Q2 2026, filed 13 Aug 2026.